Institutional Ownership
Vertex Pharmaceuticals Inc
CUSIP 92532F100COMVRTXQ1 2026
Insider Transactions
95
Form 4 lines on record
Reporting Insiders
21
Distinct officers & directors
90d Buys
0
Open-market purchase shares
90d Sells
22.5K
Open-market sale shares
Insider Transactions — Form 4
95 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Jul 21, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A · Grant | 8.3K | — | — | 53.6K | SEC |
| 2 | Jul 21, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A · Grant | 8.3K | — | — | 66.5K | SEC |
| 3 | Jul 15, 2026 | Sachs Bruce I | Director | A · Grant | 100 | $475.28 | $47.5K | 15.8K | SEC |
| 4 | Jul 15, 2026 | Garber Alan M | Director | A · Grant | 32 | $475.28 | $15.0K | 65 | SEC |
| 5 | Jul 2, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S · Sell | 1.5K | $524.99 | $787.5K | 45.3K | SEC |
| 6 | Jul 2, 2026 | Mckechnie Duncan | EVP, Chief Commercial Officer | S · Sell | 1.5K | $519.00 | $799.8K | 11.0K | SEC |
| 7 | Jul 1, 2026 | Liu Joy | EVP and Chief Legal Officer | S · Sell | 828 | $502.71 | $416.2K | 19.1K | SEC |
| 8 | Jun 26, 2026 | Bozic Carmen | EVP and CMO | S · Sell | 596 | $482.50 | $287.6K | 15.3K | SEC |
| 9 | Jun 18, 2026 | Bozic Carmen | EVP and CMO | S · Sell | 1.0K | $462.17 | $471.4K | 15.9K | SEC |
| 10 | Jun 15, 2026 | Bozic Carmen | EVP and CMO | S · Sell | 4.1K | $450.00 | $1.83M | 17.0K | SEC |
85 more insider transactions on Premium
See the full Form 4 transaction history for Vertex Pharmaceuticals Inc.
Unlock all transactions